Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Indian J Hematol Blood Transfus

Search In Journal Title:

Abbravation: Indian Journal of Hematology and Blood Transfusion

Search In Journal Abbravation:

Publisher

Springer India

Search In Publisher:

DOI

10.1002/hipo.20988

Search In DOI:

ISSN

0974-0449

Search In ISSN:
Search In Title Of Papers:

Cobalamin Deficiency Can Mask Depleted Body Iron R

Authors: Soner Solmaz Hakan Özdoğu Can Boğa
Publish Date: 2014/06/14
Volume: 31, Issue: 2, Pages: 255-258
PDF Link

Abstract

Vitamin B12 deficiency impairs DNA synthesis and causes erythroblast apoptosis resulting in anaemia from ineffective erythropoiesis Iron and cobalamin deficiency are found together in patients for various reasons We have observed that cobalamin deficiency masks iron deficiency in some patients We hypothesised that iron is not used by erythroblasts because of ineffective erythropoiesis due to cobalamin deficiency Therefore we aimed to demonstrate that depleted iron body reserves are masked by cobalamin deficiency Seventyfive patients who were diagnosed with cobalamin deficiency were enrolled in this study Complete blood counts and serum levels of iron unsaturated iron binding capacity UIBC ferritin vitamin B12 and thyroid stimulant hormone were determined at diagnosis and after cobalamin therapy Patients who had a combined deficiency at diagnosis and after cobalamin therapy were recorded Before cobalamin therapy we found increased serum iron levels 1264 ± 634 µg/dL decreased serum UIBC levels 1437 ± 708 µg/dL increased serum ferritin levels 1925 ± 1164 ng/mL and increased transferrin saturation values 472 ± 235  After cobalamin therapy serum iron levels 591 ± 30 µg/dL serum ferritin levels 449 ± 389 ng/mL and transferrin saturation values 175 ± 96  decreased and serum UIBC levels 2959 ± 806 µg/dL increased Significant differences were observed in all values p  00001 Seven patients 93  had iron deficiency before cobalamin therapy 37 493  had iron deficiency after cobalamin therapy and a significant difference was detected between the proportions of patients who had iron deficiency p  00001 This study is important because insufficient data are available on this condition Our results indicate that iron deficiency is common in patients with cobalamin deficiency and that cobalamin deficiency can mask iron deficiency Therefore we suggest that all patients diagnosed with cobalamin deficiency should be screened for iron deficiency particularly after cobalamin therapy


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Essential Thrombocythaemia: A Single Institution Experience of 16 Years
  2. Flow cytometry detection of platelets autoantibodies in children with idiopathic thrombocytopenic purpura
  3. Hypercalcemia in Tumor Lysis Syndrome
  4. Concurrent Chronic Lymphocytic Leukemia and Merkel Cell Carcinoma in Primary Skin Tumor and Metastatic Lymph Node
  5. l -carnitine as a Potential Additive in Blood Storage Solutions: A Study on Erythrocytes
  6. Hematological and Molecular Characterization of Hb J-Buda [α61(E10)Lys → Asn, AAG > AAT]
  7. Hypertriglyceridemia Thalassemia Syndrome: A Report of 4 Cases
  8. Anti Rh Hemolytic Disease due to Anti C Antibody: Is Testing for Anti D Antibodies Enough?
  9. Superior vena cava syndrome in children
  10. Rational Use of Recombinant Factor VIIa in Clinical Practice
  11. High Incidence of Zidovudine Induced Anaemia in HIV Infected Patients in Southern Odisha
  12. Editorial
  13. CD56 Negative Aggressive T Cell Large Granular Lymphocytic Leukemia
  14. Anaphylactic Shock Secondary to Intravenous Iron Sucrose in Chronic Kidney Disease
  15. Management of Acquired Haemophilia Bleed in the Backdrop of Multiple Myeloma
  16. Discrepancy in Optical & Mechanical Method in Coagulation Tests in a Turbid Sample
  17. Sickle Cell Anemia with Malaria: A Rare Case Report
  18. Flow cytometry in acute leukemia
  19. Current Role of Genetics in Hematologic Malignancies
  20. Incidence of Red Cell Alloantibody among the Transfusion Recipients of Universiti Kebangsaan Malaysia Medical Centre
  21. Turnaround Time (TAT): Difference in Concept for Laboratory and Clinician
  22. Cyclosporine Plus Methotrexate or Cyclosporine Plus Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis in Acute Leukemia Transplant: Comparison of Toxicity, Engraftment Kinetics and Transplant Outcome

Search Result: